Potential repurposing of the HDAC inhibitor valproic acid for patients with COVID-19
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potential repurposing of the HDAC inhibitor valproic acid for patients with COVID-19
Authors
Keywords
Valproic acid, COVID-19, Severe acute respiratory syndrome, Histone deacetylase inhibitor, Acute respiratory distress syndrome
Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 898, Issue -, Pages 173988
Publisher
Elsevier BV
Online
2021-03-03
DOI
10.1016/j.ejphar.2021.173988
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Deep Vein Thrombosis in Hospitalized Patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China: Prevalence, Risk Factors, and Outcome
- (2020) Li Zhang et al. CIRCULATION
- The Variety of Cardiovascular Presentations of COVID-19
- (2020) Justin A. Fried et al. CIRCULATION
- Will Complement Inhibition Be the New Target in Treating COVID-19–Related Systemic Thrombosis?
- (2020) Courtney M. Campbell et al. CIRCULATION
- Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study
- (2020) Qiao Shi et al. DIABETES CARE
- Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State
- (2020) Matt Arentz et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up
- (2020) Behnood Bikdeli et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Hypercoagulability of COVID‐19 patients in Intensive Care Unit. A Report of Thromboelastography Findings and other Parameters of Hemostasis
- (2020) Mauro Panigada et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Kidney disease is associated with in-hospital death of patients with COVID-19
- (2020) Yichun Cheng et al. KIDNEY INTERNATIONAL
- Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China
- (2020) Hua Su et al. KIDNEY INTERNATIONAL
- Endothelial cell infection and endotheliitis in COVID-19
- (2020) Zsuzsanna Varga et al. LANCET
- Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
- (2020) Maximilian Ackermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
- (2020) Yan Zhang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19)
- (2020) Riccardo M. Inciardi et al. JAMA Cardiology
- Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)
- (2020) Tao Guo et al. JAMA Cardiology
- Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China
- (2020) Shaobo Shi et al. JAMA Cardiology
- Gender Differences in Patients With COVID-19: Focus on Severity and Mortality
- (2020) Jian-Min Jin et al. Frontiers in Public Health
- Platelet Gene Expression and Function in COVID-19 Patients
- (2020) Bhanu Kanth Manne et al. BLOOD
- Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System
- (2020) Seda Bilaloglu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past
- (2020) Dimitrios Giannis et al. JOURNAL OF CLINICAL VIROLOGY
- Factors associated with COVID-19-related death using OpenSAFELY
- (2020) Elizabeth J. Williamson et al. NATURE
- Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis
- (2020) F.A. Klok et al. THROMBOSIS RESEARCH
- Incidence of thrombotic complications in critically ill ICU patients with COVID-19
- (2020) F.A. Klok et al. THROMBOSIS RESEARCH
- Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study
- (2020) George Goshua et al. Lancet Haematology
- The laboratory tests and host immunity of COVID-19 patients with different severity of illness
- (2020) Feng Wang et al. JCI Insight
- A Prospective Study of Neurologic Disorders in Hospitalized COVID-19 Patients in New York City
- (2020) Jennifer A. Frontera et al. NEUROLOGY
- Exploring the Drug Repurposing Versatility of Valproic Acid as a Multifunctional Regulator of Innate and Adaptive Immune Cells
- (2019) Rodolfo Soria-Castro et al. Journal of Immunology Research
- HDAC (Histone Deacetylase) Inhibitor Valproic Acid Attenuates Atrial Remodeling and Delays the Onset of Atrial Fibrillation in Mice
- (2019) Beatrix Scholz et al. Circulation-Arrhythmia and Electrophysiology
- Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry
- (2018) Torbjörn Tomson et al. LANCET NEUROLOGY
- Anti-angiogenic effects of valproic acid in a mouse model of oxygen-induced retinopathy
- (2018) Naoto Iizuka et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- HDAC inhibitor valproic acid protects heart function through Foxm1 pathway after acute myocardial infarction
- (2018) Shuo Tian et al. EBioMedicine
- Sodium Valproate, a Histone Deacetylase Inhibitor, Is Associated With Reduced Stroke Risk After Previous Ischemic Stroke or Transient Ischemic Attack
- (2017) Rebecca L. Brookes et al. STROKE
- Does Valproic Acid Have Potential in the Treatment of Diabetes Mellitus?
- (2017) Aleksei Rakitin Frontiers in Endocrinology
- Valproic acid reduces insulin-resistance, fat deposition and FOXO1-mediated gluconeogenesis in type-2 diabetic rat
- (2016) Sabbir Khan et al. BIOCHIMIE
- Valproic acid inhibits the angiogenic potential of cervical cancer cells via HIF-1α/VEGF signals
- (2016) Y. Zhao et al. Clinical & Translational Oncology
- Amelioration of bleomycin-induced lung fibrosis in rats by valproic acid and butyrate: Role of nuclear factor kappa-B, proinflammatory cytokines and oxidative stress
- (2016) Ahmed M. Kabel et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Valproic acid selectively increases vascular endothelial tissue-type plasminogen activator production and reduces thrombus formation in the mouse
- (2016) P. Larsson et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Valproic acid ameliorates coxsackievirus-B3-induced viral myocarditis by modulating Th17/Treg imbalance
- (2016) Haibin Jin et al. Virology Journal
- Sodium valproate ameliorates diabetes-induced fibrosis and renal damage by the inhibition of histone deacetylases in diabetic rat
- (2015) Sabbir Khan et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Valproate attenuates diabetic nephropathy through inhibition of endoplasmic reticulum stress-induced apoptosis
- (2015) XIN-YI SUN et al. Molecular Medicine Reports
- Safety of valproic acid in patients with chronic obstructive pulmonary disease: a population-based cohort study
- (2015) Tony Antoniou et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis
- (2015) Martina Korfei et al. THORAX
- Protective Effects of Valproic Acid, a Histone Deacetylase Inhibitor, against Hyperoxic Lung Injury in a Neonatal Rat Model
- (2015) Merih Cetinkaya et al. PLoS One
- Is Sodium Valproate, an HDAC inhibitor, associated with reduced risk of stroke and myocardial infarction? A nested case-control study
- (2014) Alex Dregan et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Profibrinolytic Effect of the Epigenetic Modifier Valproic Acid in Man
- (2014) Ott Saluveer et al. PLoS One
- The Androgen-Regulated Protease TMPRSS2 Activates a Proteolytic Cascade Involving Components of the Tumor Microenvironment and Promotes Prostate Cancer Metastasis
- (2014) J. M. Lucas et al. Cancer Discovery
- Histone Deacetylase Inhibition Attenuates Transcriptional Activity of Mineralocorticoid Receptor Through Its Acetylation and Prevents Development of Hypertension
- (2013) Hae-Ahm Lee et al. CIRCULATION RESEARCH
- Middle East Respiratory Syndrome Coronavirus Infection Mediated by the Transmembrane Serine Protease TMPRSS2
- (2013) Kazuya Shirato et al. JOURNAL OF VIROLOGY
- Histone Deacetylase Inhibition by Sodium Valproate Regulates Polarization of Macrophage Subsets
- (2011) Chenming Wu et al. DNA AND CELL BIOLOGY
- Wfs1 mutation makes mice sensitive to insulin-like effect of acute valproic acid and resistant to streptozocin
- (2011) Anton Terasmaa et al. JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY
- Valproic Acid Attenuates Proteinuria and Kidney Injury
- (2011) K. Van Beneden et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Valproic acid reversed pathologic endothelial cell gene expression profile associated with ischemia–reperfusion injury in a swine hemorrhagic shock model
- (2011) Marlin Wayne Causey et al. JOURNAL OF VASCULAR SURGERY
- Effects of epilepsy and selected antiepileptic drugs on risk of myocardial infarction, stroke, and death in patients with or without previous stroke: a nationwide cohort study
- (2011) Jonas Bjerring Olesen et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Inhibition of Enveloped Virus Infection of Cultured Cells by Valproic Acid
- (2010) A. Vazquez-Calvo et al. JOURNAL OF VIROLOGY
- Chronic administration of valproic acid inhibits activation of mouse hepatic stellate cellsin vitroandin vivo
- (2009) Inge Mannaerts et al. HEPATOLOGY
- Metabolic Alterations During Valproic Acid Treatment: A Prospective Study
- (2009) Ayhan Abaci et al. PEDIATRIC NEUROLOGY
- Oral valproic acid for epilepsy - long-term experience in therapy and side effects
- (2008) Thorsten Gerstner et al. EXPERT OPINION ON PHARMACOTHERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More